Rabbit Anti-CYP26A1 Recombinant Antibody (CBCNC-558) (V2LY-0125-LY936)

Horiguchi, K., Fujiwara, K., Tsukada, T., Nakakura, T., Yoshida, S., Hasegawa, R., & Takigami, S. (2022). The multiciliated cells in Rathke’s cleft express CYP26A1 and respond to retinoic acid in the pituitary. Cell and Tissue Research, 1-12.

Chen, P. H., Chung, C. M., Wang, Y. Y., Huang, H. W., Huang, B., Lee, K. W., ... & Chan, L. P. (2020). CYP26A1 is a novel biomarker for betel quid-related oral and pharyngeal cancers. Diagnostics, 10(11), 982.

Sharma, S., Liu, J., Zhang, X., Sharma, S. S., Sorensen, E. J., & Bureik, M. (2020). New luciferin-based probe substrates for human CYP26A1. Biochemistry and biophysics reports, 24, 100861.

Snyder, J. M., Zhong, G., Hogarth, C., Huang, W., Topping, T., LaFrance, J., ... & Isoherranen, N. (2020). Knockout of Cyp26a1 and Cyp26b1 during postnatal life causes reduced lifespan, dermatitis, splenomegaly, and systemic inflammation in mice. The FASEB Journal, 34(12), 15788-15804.

Guo, P., Ji, Z., Jiang, H., Huang, X., Wang, C., & Pan, B. (2020). Identification of a novel CYP26A1 mutation in a Chinese family with congenital microtia. International Journal of Pediatric Otorhinolaryngology, 139, 110488.

Zhong, G., Hogarth, C., Snyder, J. M., Palau, L., Topping, T., Huang, W., ... & Isoherranen, N. (2019). The retinoic acid hydroxylase Cyp26a1 has minor effects on postnatal vitamin A homeostasis, but is required for exogenous atRA clearance. Journal of Biological Chemistry, 294(29), 11166-11179.

Zolfaghari, R., Mattie, F. J., Wei, C. H., Chisholm, D. R., Whiting, A., & Ross, A. C. (2019). CYP26A1 gene promoter is a useful tool for reporting RAR-mediated retinoid activity. Analytical biochemistry, 577, 98-109.

Jin, L., Chang, C., Pawlik, K. M., Datta, A., Johnson, L. M., Vu, T., ... & Datta, P. K. (2018). Serine threonine kinase receptor-associated protein deficiency impairs mouse embryonic stem cells lineage commitment through CYP26A1-mediated retinoic acid homeostasis. Stem Cells, 36(9), 1368-1379.

Stevison, F., Hogarth, C., Tripathy, S., Kent, T., & Isoherranen, N. (2017). Inhibition of the all-trans retinoic acid (atRA) hydroxylases CYP26A1 and CYP26B1 results in dynamic, tissue-specific changes in endogenous atRA signaling. Drug Metabolism and Disposition, 45(7), 846-854.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols